@HealthcareGlob1 Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies; https://t.co/mFerELddrc
@DrEricDing @IanShepherdson There are also other articles on β-Glucans as immunity activation alternatives. "Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan" https://t.co/qe5URr
Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan | Thrombosis Journal | Full Text https://t.co/nfiIROjN7z
RT @NCRM: Potentials of a biological response modifier glucan (AFO-202 strain of Aureobasidium Pullulans produced Nichi Glucan) as a prophy…
Potentials of a biological response modifier glucan (AFO-202 strain of Aureobasidium Pullulans produced Nichi Glucan) as a prophylaxis against Coagulopathy associated with COVID-19, strategies, published in Thrombosis journal: https://t.co/IoMgSKP4q2.